Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,375,635
+$938,084 QoQ
Shares Held
9,354
+59.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,208
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sound Income Strategies, LLC holds $77,276,482 across 11 Drug Manufacturers - General names. JNJ ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
96,903 | $24,384,670 | |
| 2 | PFE |
Pfizer Inc
|
805,732 | $19,402,026 | |
| 3 | GSK |
GSK plc
|
339,055 | $17,773,263 | |
| 4 | LLY |
ELI LILLY & Co
|
5,822 | $6,983,082 | |
| 5 | SNY |
Sanofi
|
90,957 | $3,880,225 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
9,354 | $2,375,635 | |
| 7 | AMGN |
Amgen Inc
|
2,246 | $813,321 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,917 | $631,834 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,375,635 | 9,354 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,437,551 | 5,881 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,200,103 | 5,799 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,037,239 | 5,594 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,038,700 | 6,800 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,026,383 | 6,189 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $933,666 | 6,456 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,078,995 | 6,658 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,012,158 | 6,925 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $966,382 | 6,109 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $850,471 | 5,426 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $652,436 | 4,189 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $8,632,364 | 52,153 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $7,481,695 | 48,269 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $7,725,081 | 43,731 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $6,407,796 | 39,225 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $6,503,256 | 36,636 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $5,780,533 | 32,616 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $5,016,114 | 29,322 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $5,089,672 | 31,515 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $4,541,717 | 27,569 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $4,306,956 | 26,206 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $3,876,584 | 24,632 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $2,890,951 | 19,418 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,471,290 | 17,573 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $2,633,221 | 20,081 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||